Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identificadores![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identificadores
Visualización o descarga de ficheros![](/xmlui/themes/Mirage2//images/despl_contenidos.png)
Visualización o descarga de ficheros
Fecha de publicación
2020Título de revista
Clinical & Translational Oncology
Tipo de contenido
Journal Article
DeCS
apoyo nutricional | estadificación de neoplasias | radioterapia | diagnóstico | neoplasias pancreáticas | humanos | cuidados paliativos | pancreatectomía | ecoendoscopiaMeSH
Palliative Care | Neoplasm Staging | Radiotherapy | Humans | Endosonography | Diagnosis | Pancreatic Neoplasms | Pancreatectomy | Nutritional SupportResumen
Pancreatic cancer (PC) remains one of the most aggressive tumors with an increasing incidence rate and reduced survival. Although surgical resection is the only potentially curative treatment for PC, only 15-20% of patients are resectable at diagnosis. To select the most appropriate treatment and thus improve outcomes, the diagnostic and therapeutic strategy for each patient with PC should be discussed within a multidisciplinary expert team. Clinical decision-making should be evidence-based, considering the staging of the tumor, the performance status and preferences of the patient. The aim of this guideline is to provide practical and evidence-based recommendations for the management of PC.
![](/xmlui/themes/Mirage2//images/final_lines.png)